Oxidative Stress and Lysosomal Dysfunction in Neurodegenerative Diseases: Underlying Mechanisms and Nanotherapeutic Targeting Strategies
Top Cited Papers
Open Access
- 6 January 2026
- journal article
- review article
- Published by MDPI AG in Antioxidants
- Vol. 15 (1) , 73
Abstract
Neurodegenerative diseases (NDDs), defined by the progressive loss of neurons, present a major challenge to global health. Oxidative stress and lysosomal dysfunction are both key pathogenic factors in NDDs, and they do not operate in isolation; instead, the vicious cycle they form, often mediated through organellar crosstalk, serves as the core driver of the pathological progression of NDDs, collectively worsening disease outcomes. Specifically, excessive reactive oxygen species (ROS) can disrupt lysosomal membrane integrity through lipid peroxidation and inhibit the activity of vacuolar ATPase (V-ATPase), ultimately leading to impaired lysosomal acidification. Meanwhile, lysosomal dysfunction hinders the clearance of damaged mitochondria (the primary endogenous source of ROS), toxic protein aggregates, and free iron ions. This further exacerbates ROS accumulation and accelerates neuronal degeneration. Conventional therapeutic approaches have limited efficacy, primarily due to the challenges in crossing the blood–brain barrier (BBB), insufficient targeting ability, and an inability to effectively intervene in this pathological loop. Nanotherapeutics, leveraging their tunable physicochemical properties and modular functional design, represent a transformative strategy to address these limitations. This review systematically elaborates on the reciprocal interplay between oxidative stress and lysosomal dysfunction in NDDs, with a particular focus on the central role of lysosome-mitochondria axis dysfunction, critically appraises recent advances in nanotechnology-based targeted therapies, and thereby provides a comprehensive theoretical framework to guide the development of novel NDD therapeutics.Keywords
Funding Information
- the Project of Natural Science Foundation of Liaoning Province (2019-ZD-0943)
This publication has 199 references indexed in Scilit:
- Targeted ROS Scavenging for Disease Therapies Using NanomaterialsAdvanced Materials, 2025
- Association of environmental exposome and cognitive function among older adults with and without preclinical Alzheimer's diseaseAlzheimer's & Dementia, 2025
- Targeting the Labile Iron Pool with Engineered DFO Nanosheets to Inhibit Ferroptosis for Parkinson's Disease TherapyAdvanced Materials, 2024
- Black Phosphorus Nanosheets Protect Neurons by Degrading Aggregative α‐syn and Clearing ROS in Parkinson's DiseaseAdvanced Materials, 2024
- Harnessing Nanochaperone‐Mediated Autophagy for Selective Clearance of Pathogenic Tau Protein in Alzheimer's DiseaseAdvanced Materials, 2024
- Macrophage Membrane‐Modified MoS2 Quantum Dots as a Nanodrug for Combined Multi‐Targeting of Alzheimer's DiseaseAdvanced Healthcare Materials, 2023
- Catalytic‐Enhanced Lactoferrin‐Functionalized Au‐Bi2Se3 Nanodots for Parkinson's Disease Therapy via Reactive Oxygen Attenuation and Mitochondrial ProtectionAdvanced Healthcare Materials, 2021
- Degradable Nanoparticles Restore Lysosomal pH and Autophagic Flux in Lipotoxic Pancreatic Beta CellsAdvanced Healthcare Materials, 2019
- Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological DiseasesAdvanced Materials, 2018
- A Boronic Acid Conjugate of Angiogenin that Shows ROS‐Responsive Neuroprotective ActivityAngewandte Chemie International Edition, 2017